We are live on ! Find out more
PM

Prosight Management Portfolio holdings

AUM $580M
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
-15.01%
1 Year Est. Return
+29.81%
3 Year Est. Return
+39.55%
5 Year Est. Return
-6.93%
10 Year Est. Return
–
AUM
$316M
AUM Growth
-$26.1M
Cap. Flow
+$40.1M
Cap. Flow %
12.7%
Top 10 Hldgs %
62.9%
Holding
48
New
11
Increased
11
Reduced
18
Closed
7

Top Buys

Rank Stock Value
1
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$12.2M
2
PCRX icon
Pacira BioSciences
PCRX
+$12M
3
INSP icon
Inspire Medical Systems
INSP
+$10.1M
4
MDT icon
Medtronic
MDT
+$7.53M
5
DXCM icon
DexCom
DXCM
+$7.04M

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$9.48M
2
MIRM icon
Mirum Pharmaceuticals
MIRM
+$8.8M
3
CNC icon
Centene
CNC
+$7.7M
4
UNH icon
UnitedHealth
UNH
+$7.21M
5
MRVI icon
Maravai LifeSciences
MRVI
+$3.91M

Sector Composition

Rank Sector Weight
1 Healthcare 99.39%
2 Industrials 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCRX icon
1
Pacira BioSciences
PCRX
$1.03B
$37.1M 11.77%
1,210,377
+332,791
+38% +$12M
HUM icon
2
Humana
HUM
$46.3B
$31.6M 10.02%
65,000
+9,900
+18% +$4.65M
LKFT
3
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.89B
$25.2M 8%
730,207
+312,707
+75% +$12.2M
MGTX icon
4
MeiraGTx Holdings
MGTX
$1.33B
$20M 6.35%
4,078,804
– –
KURA icon
5
Kura Oncology
KURA
$1.13B
$17.6M 5.59%
1,932,456
+589,097
+44% +$5.98M
BCRX icon
6
BioCryst Pharmaceuticals
BCRX
$2.51B
$17M 5.4%
2,408,135
-91,865
-4% -$660K
ORIC icon
7
Oric Pharmaceuticals
ORIC
$1.37B
$15.6M 4.95%
2,579,802
-181,666
-7% -$1.49M
MDT icon
8
Medtronic
MDT
$117B
$11.8M 3.73%
150,000
+90,000
+150% +$7.53M
ABCL icon
9
AbCellera Biologics
ABCL
$3.68B
$11.3M 3.57%
2,446,000
-104,000
-4% -$633K
MIRM icon
10
Mirum Pharmaceuticals
MIRM
$5.94B
$11.2M 3.54%
353,508
-321,492
-48% -$8.8M
NBIX icon
11
Neurocrine Biosciences
NBIX
$15.7B
$9M 2.85%
80,000
-90,000
-53% -$9.48M
NARI
12
DELISTED
Inari Medical, Inc. Common Stock
NARI
$8.5M 2.69%
130,000
+11,316
+10% +$712K
INSP icon
13
Inspire Medical Systems
INSP
$1.78B
$7.94M 2.52%
+40,000
New +$10.1M
OPCH icon
14
Option Care Health
OPCH
$3.58B
$7.12M 2.26%
220,000
-15,780
-7% -$532K
QDEL icon
15
QuidelOrtho
QDEL
$1.01B
$6.21M 1.97%
85,000
-25,468
-23% -$2.03M
PRTA icon
16
Prothena Corp
PRTA
$479M
$6.09M 1.93%
126,202
+6,202
+5% +$368K
NSTG
17
DELISTED
NanoString Technologies, Inc.
NSTG
$5.93M 1.88%
3,446,274
+1,446,274
+72% +$4.4M
DXCM icon
18
DexCom
DXCM
$34.3B
$5.82M 1.85%
+62,421
New +$7.04M
KZR
19
DELISTED
Kezar Life Sciences
KZR
$5.68M 1.8%
477,080
+11,888
+3% +$211K
CNC icon
20
Centene
CNC
$32B
$5.51M 1.75%
80,000
-115,670
-59% -$7.7M
UHS icon
21
Universal Health Services
UHS
$10.1B
$5.14M 1.63%
+40,890
New +$5.58M
ADCT icon
22
ADC Therapeutics
ADCT
$146M
$4.85M 1.54%
5,402,041
-181,859
-3% -$242K
TDOC icon
23
Teladoc Health
TDOC
$1.18B
$4.65M 1.47%
250,000
+173,100
+225% +$4.04M
MASI
24
DELISTED
Masimo
MASI
$3.51M 1.11%
+40,000
New +$4.66M
LENZ
25
LENZ Therapeutics
LENZ
$161M
$3.32M 1.05%
191,118
-51,739
-21% -$900K
1
2

Similar funds

SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
CCWM
Correct Capital Wealth Management Clayton, Missouri $580M AUM 16.45% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
RIS
Retirement Income Solutions Ann Arbor, Michigan $581M AUM 19.42% 1-Year Est. Return
MFS
McNamara Financial Services Marshfield, Massachusetts $580M AUM 17.89% 1-Year Est. Return
GFI
Global Frontier Investments Charleston, South Carolina $581M AUM 8.55% 1-Year Est. Return
PWM
Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return
CA
COFG Advisors Oak Brook, Illinois $579M AUM

Prosight Management's Q3 2023 Portfolio in Review

As of Q3 2023, Prosight Management held 48 positions worth $316M, down 7.6% from $342M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Prosight Management deployed $40.1M of net new capital in Q3 2023, opening 11 new positions and adding to 11 existing holdings. Its largest new stake was Inspire Medical Systems: 40,000 shares worth $7.94M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Neurocrine Biosciences, an estimated $9.48M trimmed.

  • Prosight Management's largest Q3 2023 buy was Inspire Medical Systems: 40,000 shares worth $7.94M.
  • Prosight Management added most to Lakefront Biotherapeutics American Depositary Shares in Q3 2023, an estimated $12.2M increase.
  • Prosight Management's biggest Q3 2023 reduction was Neurocrine Biosciences, cutting an estimated $9.48M.
  • Prosight Management fully exited UnitedHealth in Q3 2023, selling an estimated $7.21M.
  • Prosight Management's ten largest holdings make up 63% of its $316M portfolio in Q3 2023.
  • Prosight Management opened 11 new positions and closed 7 in Q3 2023.
  • Prosight Management's portfolio value fell 7.6% quarter-over-quarter to $316M.

Based on Prosight Management's 13F filing for Q3 2023, filed 14 Nov 2023.